American Capital Advisory’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01K | Hold |
200
| – | – | ﹤0.01% | 495 |
|
|
2025
Q1 | $1.06K | Hold |
200
| – | – | ﹤0.01% | 423 |
|
|
2024
Q4 | $1.35K | Hold |
200
| – | – | ﹤0.01% | 414 |
|
|
2024
Q3 | $1.32K | Hold |
200
| – | – | ﹤0.01% | 403 |
|
|
2024
Q2 | $1.97K | Buy |
+200
| New | +$1.97K | ﹤0.01% | 355 |
|
|
2024
Q1 | – | Sell |
-200
| Closed | -$1.97K | – | 502 |
|
|
2023
Q4 | $1.97K | Buy |
+200
| New | +$1.97K | ﹤0.01% | 355 |
|